Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Mori J. Krantz"'
Autor:
Amelia Iglesias, Ashley Ambrose, Stephanie Coronel-Mockler, Kristin Kilbourn, Marc P. Bonaca, Raymond O. Estacio, Mori J. Krantz
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Community Heart Health Actions for Latinos at Risk (CHARLAR) is a promotora-led cardiovascular disease (CVD) risk-reduction program for socio-demographically disadvantaged Latinos and consists of 11 skill-building sessions. The CO
Externí odkaz:
https://doaj.org/article/9607bb16616b4863843eda8e4084c53e
Autor:
Michael G. Klein, Mori J. Krantz, Naheed Fatima, Ashlie Watters, Dayan Colon‐Sanchez, Robert M. Geiger, Robert E. Goldstein, Soroosh Solhjoo, Philip S. Mehler, Thomas P. Flagg, Mark C. Haigney
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background Methadone is associated with a disproportionate risk of sudden death and ventricular tachyarrhythmia despite only modest inhibition of delayed rectifier K+ current (IKr), the principal mechanism of drug‐associated arrhythmia. Congenital
Externí odkaz:
https://doaj.org/article/4836ae533faf4cd6a1dc608576af254e
Publikováno v:
Clinical Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Many volatile chemicals inhaled for a recreational high have a chemical structure similar to chloroform and may lead to Ikr blockade and subsequent torsades de pointes. This is one potential mechanism of action for huffing‐associated sudde
Externí odkaz:
https://doaj.org/article/82db8b8a15d44d67bb411c81f5d8415a
Publikováno v:
Health Equity, Vol 3, Iss 1, Pp 287-296 (2019)
Purpose: Women and minorities with acute myocardial infarction (AMI) often fail to recognize prodromal symptoms leading to delays in care. The objective of this study was to conduct a mixed method assessment of the impact of ethnicity on symptom desc
Externí odkaz:
https://doaj.org/article/7a5c1238cd7f436f8f211151d4313569
Autor:
Maria Odette Gore, Mori J. Krantz, Karen Albright, Brenda Beaty, Stephanie Coronel-Mockler, Sheana Bull, Raymond O. Estacio
Publikováno v:
Preventive Medicine Reports, Vol 13, Iss , Pp 126-131 (2019)
The statewide Colorado Healthy Heart Solutions (CHHS) program provides cardiovascular disease (CVD) risk factor screening and education to the medically underserved and has been shown to improve CVD risk profiles. We aimed to enhance its effectivenes
Externí odkaz:
https://doaj.org/article/9f5b66a11e6740ef91bc57a5a95fbf29
Publikováno v:
HeartRhythm Case Reports, Vol 3, Iss 2, Pp 141-144 (2017)
Externí odkaz:
https://doaj.org/article/c4228fdd21584446b2095a749d33db46
Publikováno v:
International Journal of Eating Disorders. 55:633-636
The exact medical complications, leading to the well-known high risk of death in patients with anorexia nervosa (AN), remain elusive. Such deaths are often abrupt with no satisfactory explanation. Suspected causes include cardiac QTc prolongation and
Autor:
Mori J. Krantz, Marc P. Bonaca, Kristin Kilbourn, Raymond O. Estacio, Stephanie Coronel-Mockler, Amelia Iglesias, Ashley Ambrose
Publikováno v:
BMC Public Health. 22
Background Community Heart Health Actions for Latinos at Risk (CHARLAR) is a promotora-led cardiovascular disease (CVD) risk-reduction program for socio-demographically disadvantaged Latinos and consists of 11 skill-building sessions. The COVID-19 pa
Autor:
Mori J, Krantz, Todd, Rudo, Blaine, Horvath, Elizabeth, Gregory, Morteza, Farasat, Odette, Gore, Philip S, Mehler
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 21:93-95
Ascertainment of the left ventricular ejection fraction is the primary reason for ordering echocardiography in the acute care setting; however, this parameter does not provide information regarding a patient's volume status. As such, it cannot be rel
Autor:
Sebastian Debus, Lloyd Haskell, Marc P. Bonaca, Manesh R. Patel, Eva Muehlhofer, Michael Szarek, Mori J. Krantz, Patrice Nault, Sonia S. Anand, Lajos Mátyás, William R. Hiatt, Rupert Bauersachs, Judith Hsia, Mark R. Nehler, Warren H. Capell, Dainis Krievins, Scott D. Berkowitz, Stefan Stefanov, Connie N. Hess, Taylor Bracken
Publikováno v:
European Heart Journal. 42:4040-4048
Aims In this secondary analysis of the VOYAGER trial, rivaroxaban 2.5 mg twice/day plus aspirin 100 mg/day was assessed in older adults. Advanced age is associated with elevated bleeding risk and unfavourable net benefit for dual antiplatelet therapy